Enhanced Vaccine Effectiveness during the Delta Phase of the COVID-19 Pandemic in the Medicare Population Supports a Multilayered Prevention Approach
Throughout the pandemic, individuals 65 years and older have contributed most COVID-19 related deaths. To best formulate effective vaccination and other prevention policies to protect older adults, large scale observational studies of these higher risk individuals are needed. We conducted a Vaccine...
Main Authors: | Bettina Experton, Adrien Elena, Christopher S. Hein, Dale Nordenberg, Peter Walker, Blake Schwendiman, Christopher R. Burrow |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/11/12/1700 |
Similar Items
-
Analysis of the Delta Variant B.1.617.2 COVID-19
by: Shayan Shiehzadegan, et al.
Published: (2021-10-01) -
Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients
by: Jessica A. Plante, et al.
Published: (2022-09-01) -
Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated Individuals
by: Leonardo C. Caserta, et al.
Published: (2022-10-01) -
Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case
by: Bradley A Connor, et al.
Published: (2021-09-01) -
Histopathological Lung Findings in COVID-19 B.1.617.2 SARS-CoV-2 Delta Variant
by: Ionuț Isaia Jeican, et al.
Published: (2023-01-01)